25 XP   0   0   10

Endymed
Buy, Hold or Sell?

Let's analyse Endymed together

PenkeI guess you are interested in Endymed. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Endymed. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Endymed

I send you an email if I find something interesting about Endymed.

Quick analysis of Endymed (30 sec.)










What can you expect buying and holding a share of Endymed? (30 sec.)

How much money do you get?

How much money do you get?
ILA0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
ILA417.60
Expected worth in 1 year
ILA433.16
How sure are you?
52.5%

+ What do you gain per year?

Total Gains per Share
ILA15.56
Return On Investment
4.9%

For what price can you sell your share?

Current Price per Share
ILA320.00
Expected price per share
ILA280.00 - ILA369.80
How sure are you?
50%

1. Valuation of Endymed (5 min.)




Live pricePrice per Share (EOD)

ILA320.00

2. Growth of Endymed (5 min.)




Is Endymed growing?

Current yearPrevious yearGrowGrow %
How rich?$15.2m$14.4m$836.2k5.5%

How much money is Endymed making?

Current yearPrevious yearGrowGrow %
Making money$137.7k$211.7k-$73.9k-53.7%
Net Profit Margin1.8%3.1%--

How much money comes from the company's main activities?

3. Financial Health of Endymed (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

What can you expect buying and holding a share of Endymed? (5 min.)

Welcome investor! Endymed's management wants to use your money to grow the business. In return you get a share of Endymed.

What can you expect buying and holding a share of Endymed?

First you should know what it really means to hold a share of Endymed. And how you can make/lose money.

Speculation

The Price per Share of Endymed is ILA320.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Endymed.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Endymed, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ILA417.60. Based on the TTM, the Book Value Change Per Share is ILA3.89 per quarter. Based on the YOY, the Book Value Change Per Share is ILA6.46 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ILA0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Endymed.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ILA% of Price per ShareILA% of Price per ShareILA% of Price per ShareILA% of Price per ShareILA% of Price per Share
Usd Eps0.020.0%0.000.0%0.020.0%0.020.0%0.010.0%
Usd Book Value Change Per Share0.020.0%0.010.0%0.020.0%0.030.0%0.010.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.020.0%0.010.0%0.020.0%0.030.0%0.010.0%
Usd Price Per Share0.77-0.84-1.27-0.90-1.47-
Price to Earnings Ratio12.01-16.48-742.98-152.76-76.63-
Price-to-Total Gains Ratio50.82-39.35-134.81-51.32-17.74-
Price to Book Ratio0.69-0.76-1.21-1.11-2.94-
Price-to-Total Gains Ratio50.82-39.35-134.81-51.32-17.74-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.84736
Number of shares1180
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.03
Usd Total Gains Per Share0.010.03
Gains per Quarter (1180 shares)12.1537.91
Gains per Year (1180 shares)48.61151.63
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1049390152142
2097880303294
301461370455446
401941860607598
502432350758750
602922840910902
70340333010611054
80389382012131206
90437431013651358
100486480015161510

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%10.02.00.083.3%16.04.00.080.0%22.09.09.055.0%24.013.020.042.1%
Book Value Change Per Share3.01.00.075.0%8.02.02.066.7%13.03.04.065.0%21.015.04.052.5%27.026.04.047.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.057.00.0%
Total Gains per Share3.01.00.075.0%8.02.02.066.7%13.03.04.065.0%21.015.04.052.5%27.026.04.047.4%

Fundamentals of Endymed

About Endymed

Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Its products comprise EndyMed PRO, a multi-application treatment platform; PURE 2.0 that offers professional skin tightening, body contouring, and functional resurfacing; and 3DEEP radiofrequency technology, a solution for the treatment of skin tightening, wrinkle reduction, RF micro needling, and fractional skin resurfacing. The company was incorporated in 2004 and is based in Freehold, New Jersey.

Fundamental data was last updated by Penke on 2024-04-21 09:23:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Endymed.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Endymed earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Endymed to the Medical Devices industry mean.
  • A Net Profit Margin of 4.0% means that 0.04 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Endymed:

  • The MRQ is 4.0%. The company is making a profit. +1
  • The TTM is 1.8%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.0%TTM1.8%+2.2%
TTM1.8%YOY3.1%-1.3%
TTM1.8%5Y7.7%-5.9%
5Y7.7%10Y3.5%+4.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0%-11.2%+15.2%
TTM1.8%-18.9%+20.7%
YOY3.1%-13.9%+17.0%
5Y7.7%-21.0%+28.7%
10Y3.5%-24.6%+28.1%
1.1.2. Return on Assets

Shows how efficient Endymed is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Endymed to the Medical Devices industry mean.
  • 1.1% Return on Assets means that Endymed generated 0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Endymed:

  • The MRQ is 1.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is 0.7%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.1%TTM0.7%+0.4%
TTM0.7%YOY1.1%-0.4%
TTM0.7%5Y2.6%-1.9%
5Y2.6%10Y1.0%+1.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1%-4.0%+5.1%
TTM0.7%-4.6%+5.3%
YOY1.1%-4.4%+5.5%
5Y2.6%-3.9%+6.5%
10Y1.0%-4.9%+5.9%
1.1.3. Return on Equity

Shows how efficient Endymed is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Endymed to the Medical Devices industry mean.
  • 1.4% Return on Equity means Endymed generated 0.01 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Endymed:

  • The MRQ is 1.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.4%TTM0.9%+0.6%
TTM0.9%YOY1.5%-0.6%
TTM0.9%5Y4.1%-3.2%
5Y4.1%10Y-0.3%+4.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4%-4.1%+5.5%
TTM0.9%-5.7%+6.6%
YOY1.5%-5.5%+7.0%
5Y4.1%-6.0%+10.1%
10Y-0.3%-6.9%+6.6%

1.2. Operating Efficiency of Endymed.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Endymed is operating .

  • Measures how much profit Endymed makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Endymed to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated 0.00  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Endymed:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.0%-1.0%
TTM1.0%YOY5.4%-4.4%
TTM1.0%5Y6.8%-5.8%
5Y6.8%10Y2.5%+4.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--24.1%+24.1%
TTM1.0%-16.7%+17.7%
YOY5.4%-12.5%+17.9%
5Y6.8%-19.0%+25.8%
10Y2.5%-23.8%+26.3%
1.2.2. Operating Ratio

Measures how efficient Endymed is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.45 means that the operating costs are 1.45 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Endymed:

  • The MRQ is 1.454. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.454. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.454TTM1.454+0.001
TTM1.454YOY1.473-0.019
TTM1.4545Y1.122+0.331
5Y1.12210Y1.040+0.082
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4541.431+0.023
TTM1.4541.426+0.028
YOY1.4731.435+0.038
5Y1.1221.436-0.314
10Y1.0401.373-0.333

1.3. Liquidity of Endymed.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Endymed is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 4.43 means the company has 4.43 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Endymed:

  • The MRQ is 4.429. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.302. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.429TTM4.302+0.128
TTM4.302YOY4.437-0.135
TTM4.3025Y3.819+0.483
5Y3.81910Y2.313+1.506
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4292.726+1.703
TTM4.3022.732+1.570
YOY4.4373.496+0.941
5Y3.8193.560+0.259
10Y2.3133.507-1.194
1.3.2. Quick Ratio

Measures if Endymed is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Endymed to the Medical Devices industry mean.
  • A Quick Ratio of 0.32 means the company can pay off 0.32 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Endymed:

  • The MRQ is 0.318. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.477. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.318TTM0.477-0.159
TTM0.477YOY0.465+0.012
TTM0.4775Y0.537-0.060
5Y0.53710Y0.589-0.052
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3181.527-1.209
TTM0.4771.645-1.168
YOY0.4652.113-1.648
5Y0.5372.289-1.752
10Y0.5892.245-1.656

1.4. Solvency of Endymed.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Endymed assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Endymed to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.25 means that Endymed assets are financed with 25.5% credit (debt) and the remaining percentage (100% - 25.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Endymed:

  • The MRQ is 0.255. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.263. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.255TTM0.263-0.008
TTM0.263YOY0.264-0.001
TTM0.2635Y0.333-0.071
5Y0.33310Y0.451-0.117
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2550.393-0.138
TTM0.2630.386-0.123
YOY0.2640.337-0.073
5Y0.3330.442-0.109
10Y0.4510.461-0.010
1.4.2. Debt to Equity Ratio

Measures if Endymed is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Endymed to the Medical Devices industry mean.
  • A Debt to Equity ratio of 34.2% means that company has 0.34 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Endymed:

  • The MRQ is 0.342. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.357. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.342TTM0.357-0.015
TTM0.357YOY0.359-0.003
TTM0.3575Y0.515-0.159
5Y0.51510Y1.121-0.605
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3420.560-0.218
TTM0.3570.560-0.203
YOY0.3590.479-0.120
5Y0.5150.625-0.110
10Y1.1210.676+0.445

2. Market Valuation of Endymed

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings Endymed generates.

  • Above 15 is considered overpriced but always compare Endymed to the Medical Devices industry mean.
  • A PE ratio of 12.01 means the investor is paying 12.01 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Endymed:

  • The EOD is 13.299. Based on the earnings, the company is underpriced. +1
  • The MRQ is 12.011. Based on the earnings, the company is underpriced. +1
  • The TTM is 16.482. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD13.299MRQ12.011+1.288
MRQ12.011TTM16.482-4.471
TTM16.482YOY742.980-726.498
TTM16.4825Y152.759-136.277
5Y152.75910Y76.628+76.131
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD13.299-0.992+14.291
MRQ12.011-1.592+13.603
TTM16.482-2.128+18.610
YOY742.980-2.756+745.736
5Y152.759-2.086+154.845
10Y76.628-1.490+78.118
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Endymed:

  • The EOD is 12.833. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 11.590. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 1.614. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD12.833MRQ11.590+1.243
MRQ11.590TTM1.614+9.975
TTM1.614YOY-45.276+46.890
TTM1.6145Y-8.519+10.134
5Y-8.51910Y-4.260-4.260
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD12.833-0.936+13.769
MRQ11.590-1.487+13.077
TTM1.614-2.933+4.547
YOY-45.276-6.215-39.061
5Y-8.519-4.622-3.897
10Y-4.260-4.718+0.458
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Endymed is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 0.69 means the investor is paying 0.69 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of Endymed:

  • The EOD is 0.766. Based on the equity, the company is cheap. +2
  • The MRQ is 0.692. Based on the equity, the company is cheap. +2
  • The TTM is 0.758. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.766MRQ0.692+0.074
MRQ0.692TTM0.758-0.066
TTM0.758YOY1.214-0.456
TTM0.7585Y1.113-0.355
5Y1.11310Y2.943-1.830
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.7661.923-1.157
MRQ0.6922.377-1.685
TTM0.7582.451-1.693
YOY1.2143.215-2.001
5Y1.1133.862-2.749
10Y2.9434.187-1.244
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Endymed compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--5.6873.889+46%6.460-12%12.132-53%2.958+92%
Book Value Per Share--417.601418.6130%395.666+6%308.029+36%257.618+62%
Current Ratio--4.4294.302+3%4.4370%3.819+16%2.313+91%
Debt To Asset Ratio--0.2550.263-3%0.264-4%0.333-24%0.451-43%
Debt To Equity Ratio--0.3420.357-4%0.359-5%0.515-34%1.121-70%
Dividend Per Share----0%-0%-0%-0%
Eps--6.015-0.267+104%5.810+4%9.437-36%5.474+10%
Free Cash Flow Per Share--6.234-4.819+177%-1.709+127%8.212-24%8.212-24%
Free Cash Flow To Equity Per Share--6.234-5.913+195%-4.409+171%4.304+45%4.304+45%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.775+29%
Market Cap4403872000.000+10%3977252680.0004363619302.500-9%6599615055.000-40%4653998456.500-15%7615636637.250-48%
Net Profit Margin--0.0400.018+125%0.031+29%0.077-48%0.035+15%
Operating Margin---0.010-100%0.054-100%0.068-100%0.025-100%
Operating Ratio--1.4541.454+0%1.473-1%1.122+30%1.040+40%
Pb Ratio0.766+10%0.6920.758-9%1.214-43%1.113-38%2.943-76%
Pe Ratio13.299+10%12.01116.482-27%742.980-98%152.759-92%76.628-84%
Price Per Share320.000+10%289.000317.075-9%479.550-40%338.175-15%553.378-48%
Price To Free Cash Flow Ratio12.833+10%11.5901.614+618%-45.276+491%-8.519+174%-4.260+137%
Price To Total Gains Ratio56.272+10%50.82139.351+29%134.810-62%51.318-1%17.743+186%
Quick Ratio--0.3180.477-33%0.465-32%0.537-41%0.589-46%
Return On Assets--0.0110.007+60%0.011+2%0.026-59%0.010+10%
Return On Equity--0.0140.009+63%0.015-1%0.041-65%-0.003+119%
Total Gains Per Share--5.6873.889+46%6.460-12%12.132-53%2.958+92%
Usd Book Value--15218260.34615255127.7350%14418885.674+6%11225223.188+36%9388131.157+62%
Usd Book Value Change Per Share--0.0150.010+46%0.017-12%0.032-53%0.008+92%
Usd Book Value Per Share--1.1061.1080%1.048+6%0.816+36%0.682+62%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.016-0.001+104%0.015+4%0.025-36%0.014+10%
Usd Free Cash Flow--227182.830-175618.306+177%-62275.995+127%179554.149+27%89777.074+153%
Usd Free Cash Flow Per Share--0.017-0.013+177%-0.005+127%0.022-24%0.022-24%
Usd Free Cash Flow To Equity Per Share--0.017-0.016+195%-0.012+171%0.011+45%0.011+45%
Usd Market Cap11661453.056+10%10531765.09711554863.913-9%17475780.666-40%12323787.913-15%20166205.815-48%
Usd Price Per Share0.847+10%0.7650.840-9%1.270-40%0.895-15%1.465-48%
Usd Profit--219211.502137754.501+59%211738.383+4%429405.441-49%242228.710-10%
Usd Revenue--5438438.0915674339.560-4%5314384.309+2%4102343.984+33%4586253.376+19%
Usd Total Gains Per Share--0.0150.010+46%0.017-12%0.032-53%0.008+92%
 EOD+4 -4MRQTTM+22 -11YOY+20 -135Y+13 -2010Y+24 -10

3.2. Fundamental Score

Let's check the fundamental score of Endymed based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1513.299
Price to Book Ratio (EOD)Between0-10.766
Net Profit Margin (MRQ)Greater than00.040
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.318
Current Ratio (MRQ)Greater than14.429
Debt to Asset Ratio (MRQ)Less than10.255
Debt to Equity Ratio (MRQ)Less than10.342
Return on Equity (MRQ)Greater than0.150.014
Return on Assets (MRQ)Greater than0.050.011
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Endymed based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.739
Ma 20Greater thanMa 50321.470
Ma 50Greater thanMa 100323.162
Ma 100Greater thanMa 200320.030
OpenGreater thanClose320.000
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Selling General Administrative  311,192348,068659,26081,655740,91547,789788,704-988,514-199,810
Interest Expense  41,392-28,97412,4182,25814,675-3,76310,912-35,371-24,459
Tax Provision  63,96957,572121,542-63,21758,325-40,26318,062-28,974-10,912



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets20,489
Total Liabilities5,216
Total Stockholder Equity15,273
 As reported
Total Liabilities 5,216
Total Stockholder Equity+ 15,273
Total Assets = 20,489

Assets

Total Assets20,489
Total Current Assets17,154
Long-term Assets3,335
Total Current Assets
Cash And Cash Equivalents 9,736
Net Receivables 1,230
Inventory 5,439
Total Current Assets  (as reported)17,154
Total Current Assets  (calculated)16,405
+/- 749
Long-term Assets
Property Plant Equipment 1,541
Intangible Assets 131
Long-term Assets  (as reported)3,335
Long-term Assets  (calculated)1,672
+/- 1,663

Liabilities & Shareholders' Equity

Total Current Liabilities3,873
Long-term Liabilities1,343
Total Stockholder Equity15,273
Total Current Liabilities
Accounts payable 1,472
Total Current Liabilities  (as reported)3,873
Total Current Liabilities  (calculated)1,472
+/- 2,401
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,276
Long-term Liabilities Other 65
Long-term Liabilities  (as reported)1,343
Long-term Liabilities  (calculated)1,341
+/- 2
Total Stockholder Equity
Total Stockholder Equity (as reported)15,273
Total Stockholder Equity (calculated)0
+/- 15,273
Other
Capital Stock739
Common Stock Shares Outstanding 13,762
Net Invested Capital 15,273
Net Working Capital 13,281
Property Plant and Equipment Gross 4,623



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302011-12-312011-09-302011-06-302011-03-312010-12-312010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-31
> Total Assets 
22,259
18,391
15,534
13,170
12,666
12,256
11,134
21,459
19,013
17,131
15,082
12,677
28,706
28,429
21,256
19,961
20,232
20,814
21,080
20,737
23,133
48,227
51,817
12,800
14,016
13,239
12,018
10,738
10,020
10,673
10,384
9,458
9,504
9,521
8,804
8,607
9,193
11,082
11,748
11,690
12,417
12,249
14,094
0
12,956
0
13,551
0
16,586
0
19,596
20,154
19,500
19,326
19,697
20,533
21,452
20,608
20,489
20,48920,60821,45220,53319,69719,32619,50020,15419,596016,586013,551012,956014,09412,24912,41711,69011,74811,0829,1938,6078,8049,5219,5049,45810,38410,67310,02010,73812,01813,23914,01612,80051,81748,22723,13320,73721,08020,81420,23219,96121,25628,42928,70612,67715,08217,13119,01321,45911,13412,25612,66613,17015,53418,39122,259
   > Total Current Assets 
0
0
0
0
0
0
0
0
16,543
14,829
12,932
10,917
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,331
7,525
7,622
7,887
7,141
7,089
7,556
9,551
10,335
9,886
10,666
10,516
11,325
10,206
10,206
10,922
10,922
14,238
14,238
15,065
15,065
15,983
15,829
15,673
16,256
17,175
18,223
17,308
17,154
17,15417,30818,22317,17516,25615,67315,82915,98315,06515,06514,23814,23810,92210,92210,20610,20611,32510,51610,6669,88610,3359,5517,5567,0897,1417,8877,6227,5258,33100000000000000000010,91712,93214,82916,54300000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
1,354
747
2,591
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,479
1,661
1,221
2,501
2,559
2,811
2,879
4,948
5,918
5,018
5,133
4,868
6,473
0
5,273
0
7,255
0
11,797
0
11,318
11,737
11,572
10,748
10,648
11,477
10,813
9,494
9,736
9,7369,49410,81311,47710,64810,74811,57211,73711,318011,79707,25505,27306,4734,8685,1335,0185,9184,9482,8792,8112,5592,5011,2211,6612,4790000000000000000002,5917471,354000000000
       Net Receivables 
618
0
0
0
1,249
2,219
0
834
0
425
462
323
3,066
2,789
2,663
3,133
2,890
3,780
3,385
4,028
4,470
7,389
10,968
2,484
2,874
3,564
3,196
3,606
2,980
3,242
2,804
2,481
2,912
1,993
1,740
1,856
1,949
2,186
1,786
2,054
2,726
2,716
1,886
2,549
2,549
1,543
1,543
1,332
1,332
1,172
1,172
2,360
1,524
1,669
1,216
1,707
3,068
1,911
1,230
1,2301,9113,0681,7071,2161,6691,5242,3601,1721,1721,3321,3321,5431,5432,5492,5491,8862,7162,7262,0541,7862,1861,9491,8561,7401,9932,9122,4812,8043,2422,9803,6063,1963,5642,8742,48410,9687,3894,4704,0283,3853,7802,8903,1332,6632,7893,066323462425083402,2191,249000618
       Other Current Assets 
310
13,507
10,817
8,633
171
0
8,397
209
16,543
0
0
341
0
0
256
0
0
0
411
0
0
0
941
0
0
0
302
0
0
0
240
215
170
260
296
0
0
26
62
36
7
6
103
33
33
210
210
21
21
685
685
23
17
10
0
0
10
0
0
001000101723685685212121021033331036736622600296260170215240000302000941000411000256003410016,5432098,39701718,63310,81713,507310
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,804
1,751
1,733
2,769
0
2,750
0
2,629
0
2,348
0
4,531
4,171
3,671
3,653
3,441
3,358
3,229
3,300
3,335
3,3353,3003,2293,3583,4413,6533,6714,1714,53102,34802,62902,75002,7691,7331,7511,804000000000000000000000000000000000000000
       Property Plant Equipment 
1,973
0
0
0
1,610
1,523
0
1,357
0
1,327
1,259
1,164
1,535
1,420
1,070
1,064
981
923
946
900
845
1,036
1,870
535
576
677
773
760
716
668
836
805
833
812
753
698
649
611
577
1,023
970
901
2,103
2,121
2,121
1,990
1,990
1,955
1,955
1,808
1,808
1,749
1,655
1,644
1,596
1,511
1,439
1,530
1,541
1,5411,5301,4391,5111,5961,6441,6551,7491,8081,8081,9551,9551,9901,9902,1212,1212,1039019701,0235776116496987538128338058366687167607736775765351,8701,0368459009469239811,0641,0701,4201,5351,1641,2591,32701,35701,5231,6100001,973
       Goodwill 
2,280
0
0
0
0
0
0
0
0
0
0
0
0
0
1,113
0
0
0
578
0
0
0
143
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000001430005780001,11300000000000002,280
       Intangible Assets 
3,858
0
0
0
1,277
1,191
0
911
0
744
663
596
8,012
7,950
1,924
1,914
1,906
1,899
1,351
1,322
1,294
1,265
761
186
176
166
61
89
84
76
67
59
52
43
35
28
100
88
76
68
64
72
67
0
0
0
45
0
0
0
24
0
0
0
4
0
0
0
131
13100040002400045000677264687688100283543525967768489611661761867611,2651,2941,3221,3511,8991,9061,9141,9247,9508,012596663744091101,1911,2770003,858
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,804
1,751
1,733
2,769
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000002,7691,7331,7511,804000000000000000000000000000000000000000
> Total Liabilities 
6,305
5,875
5,717
5,351
7,743
7,784
5,589
5,033
4,349
4,604
4,162
2,663
10,214
9,717
9,543
8,865
9,528
9,438
10,135
10,953
14,415
19,567
22,152
5,427
5,258
5,265
5,596
5,390
5,725
5,713
6,353
6,331
6,623
7,164
7,532
6,902
7,034
5,406
5,349
5,177
5,195
4,846
5,928
0
4,323
0
5,080
0
6,210
0
5,837
5,724
5,028
5,049
4,993
5,133
5,950
5,543
5,216
5,2165,5435,9505,1334,9935,0495,0285,7245,83706,21005,08004,32305,9284,8465,1955,1775,3495,4067,0346,9027,5327,1646,6236,3316,3535,7135,7255,3905,5965,2655,2585,42722,15219,56714,41510,95310,1359,4389,5288,8659,5439,71710,2142,6634,1624,6044,3495,0335,5897,7847,7435,3515,7175,8756,305
   > Total Current Liabilities 
4,244
3,650
3,707
3,593
5,764
5,301
3,109
4,041
3,331
3,596
3,064
2,573
7,002
6,409
6,200
5,345
6,169
6,438
7,056
7,704
8,404
11,344
14,936
3,886
3,607
3,724
3,554
3,445
3,763
3,568
4,157
4,247
4,406
5,180
5,554
5,224
5,316
3,907
3,953
3,831
3,838
3,702
3,684
2,208
2,208
3,166
3,166
4,375
4,375
4,022
4,022
4,001
3,405
3,465
3,549
3,726
4,579
4,133
3,873
3,8734,1334,5793,7263,5493,4653,4054,0014,0224,0224,3754,3753,1663,1662,2082,2083,6843,7023,8383,8313,9533,9075,3165,2245,5545,1804,4064,2474,1573,5683,7633,4453,5543,7243,6073,88614,93611,3448,4047,7047,0566,4386,1695,3456,2006,4097,0022,5733,0643,5963,3314,0413,1095,3015,7643,5933,7073,6504,244
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
0
0
0
163
0
0
0
0
241
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000024100001630006000000000000000000040000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
0
0
0
163
0
0
0
0
241
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000024100001630006000000000000000000040000000000
       Accounts payable 
1,106
0
0
0
710
1,048
0
1,207
0
781
528
727
3,460
3,128
3,194
2,389
2,970
3,225
2,863
4,177
5,045
6,815
9,305
2,071
1,990
1,875
1,283
936
1,187
902
1,467
1,218
1,762
1,651
1,453
1,109
1,701
1,103
1,494
1,124
1,194
1,310
1,239
529
529
581
581
1,624
1,624
1,380
1,380
1,571
1,430
1,178
1,438
1,762
2,253
1,813
1,472
1,4721,8132,2531,7621,4381,1781,4301,5711,3801,3801,6241,6245815815295291,2391,3101,1941,1241,4941,1031,7011,1091,4531,6511,7621,2181,4679021,1879361,2831,8751,9902,0719,3056,8155,0454,1772,8633,2252,9702,3893,1943,1283,46072752878101,20701,0487100001,106
       Other Current Liabilities 
3,111
3,650
3,707
3,593
5,054
4,253
3,109
2,834
3,331
2,815
2,532
1,846
3,542
3,281
3,006
2,956
3,199
3,213
3,165
3,527
3,359
4,529
5,566
1,815
1,617
1,849
2,270
2,509
2,576
2,666
2,684
3,029
2,644
3,529
3,938
4,115
3,615
2,804
1,567
596
621
2,204
1,359
1,429
1,429
1,352
1,352
2,420
2,420
1,161
1,161
2,106
1,702
2,018
0
0
2,112
0
0
002,112002,0181,7022,1061,1611,1612,4202,4201,3521,3521,4291,4291,3592,2046215961,5672,8043,6154,1153,9383,5292,6443,0292,6842,6662,5762,5092,2701,8491,6171,8155,5664,5293,3593,5273,1653,2133,1992,9563,0063,2813,5421,8462,5322,8153,3312,8343,1094,2535,0543,5933,7073,6503,111
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,346
1,357
1,144
2,244
0
2,115
0
1,914
0
1,835
0
1,815
1,723
1,623
1,584
1,444
1,407
1,371
1,410
1,343
1,3431,4101,3711,4071,4441,5841,6231,7231,81501,83501,91402,11502,2441,1441,3571,346000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-6
0
0
0
-163
0
0
0
0
222
438
418
1,595
0
1,629
0
1,704
0
1,691
0
1,656
1,531
1,311
1,285
1,251
1,156
1,098
1,191
1,276
1,2761,1911,0981,1561,2511,2851,3111,5311,65601,69101,70401,62901,5954184382220000-163000-60000000000000000000-40000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,124
1,132
914
801
0
736
0
481
0
24
0
36
38
39
37
57
63
72
67
65
6567726357373938360240481073608019141,1321,124000000000000000000000000000000000000000
> Total Stockholder Equity
15,954
12,516
9,817
7,819
4,923
4,472
5,545
16,426
14,664
12,527
10,920
10,014
18,492
18,712
11,713
11,096
10,704
11,376
10,945
9,784
8,718
28,660
29,665
7,373
8,758
7,974
6,422
5,348
4,295
4,960
4,031
3,127
2,881
2,357
1,272
1,705
2,159
5,676
6,399
6,513
7,222
7,403
8,166
0
8,633
0
8,471
0
10,376
0
13,759
14,430
14,472
14,277
14,704
15,400
15,502
15,065
15,273
15,27315,06515,50215,40014,70414,27714,47214,43013,759010,37608,47108,63308,1667,4037,2226,5136,3995,6762,1591,7051,2722,3572,8813,1274,0314,9604,2955,3486,4227,9748,7587,37329,66528,6608,7189,78410,94511,37610,70411,09611,71318,71218,49210,01410,92012,52714,66416,4265,5454,4724,9237,8199,81712,51615,954
   Common Stock
204
12,516
9,817
7,819
223
224
5,545
525
14,664
525
525
525
1,159
1,177
1,177
1,177
1,177
1,177
1,177
1,177
1,177
1,656
1,657
445
472
472
472
472
473
503
504
504
504
504
504
504
504
737
737
737
737
737
737
737
737
737
737
737
737
738
738
738
739
739
739
0
739
0
0
0073907397397397387387387377377377377377377377377377377377375045045045045045045045034734724724724724451,6571,6561,1771,1771,1771,1771,1771,1771,1771,1771,15952552552514,6645255,5452242237,8199,81712,516204
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000000000000000000000000000000
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
3,307
2,906
3,032
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
173
69
-276
-561
-577
-592
-640
-711
-717
-706
-698
-701
-697
-719
-719
-757
-757
-722
-722
-672
-672
-629
-616
-591
-604
0
-594
0
0
00-5940-604-591-616-629-672-672-722-722-757-757-719-719-697-701-698-706-717-711-640-592-577-561-276691730000000000000000003,0322,9063,307000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue22,779
Cost of Revenue-11,116
Gross Profit11,66311,663
 
Operating Income (+$)
Gross Profit11,663
Operating Expense-21,784
Operating Income995-10,121
 
Operating Expense (+$)
Research Development3,010
Selling General Administrative5,286
Selling And Marketing Expenses-
Operating Expense21,7848,296
 
Net Interest Income (+$)
Interest Income146
Interest Expense-36
Other Finance Cost-33
Net Interest Income77
 
Pretax Income (+$)
Operating Income995
Net Interest Income77
Other Non-Operating Income Expenses-
Income Before Tax (EBT)1,050995
EBIT - interestExpense = -36
553
589
Interest Expense36
Earnings Before Interest and Taxes (EBIT)-1,086
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax1,050
Tax Provision-497
Net Income From Continuing Ops553553
Net Income553
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--77
 

Technical Analysis of Endymed
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Endymed. The general trend of Endymed is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Endymed's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Endymed.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 350.50 < 350.50 < 369.80.

The bearish price targets are: 283.70 > 280.00 > 280.00.

Tweet this
Endymed Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Endymed. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Endymed Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Endymed. The current macd is 0.13581779.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Endymed price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Endymed. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Endymed price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Endymed Daily Moving Average Convergence/Divergence (MACD) ChartEndymed Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Endymed. The current adx is 11.83.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Endymed shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Endymed Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Endymed. The current sar is 287.37.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Endymed Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Endymed. The current rsi is 48.74. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Endymed Daily Relative Strength Index (RSI) ChartEndymed Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Endymed. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Endymed price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Endymed Daily Stochastic Oscillator ChartEndymed Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Endymed. The current cci is -10.02597973.

Endymed Daily Commodity Channel Index (CCI) ChartEndymed Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Endymed. The current cmo is -4.1217654.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Endymed Daily Chande Momentum Oscillator (CMO) ChartEndymed Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Endymed. The current willr is -26.2195122.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Endymed is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Endymed Daily Williams %R ChartEndymed Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Endymed.

Endymed Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Endymed. The current atr is 11.70.

Endymed Daily Average True Range (ATR) ChartEndymed Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Endymed. The current obv is -1,530,473.

Endymed Daily On-Balance Volume (OBV) ChartEndymed Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Endymed. The current mfi is 59.64.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Endymed Daily Money Flow Index (MFI) ChartEndymed Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Endymed.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-10STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-24STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-28MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-31WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-03BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Endymed Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Endymed based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.739
Ma 20Greater thanMa 50321.470
Ma 50Greater thanMa 100323.162
Ma 100Greater thanMa 200320.030
OpenGreater thanClose320.000
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Endymed with someone you think should read this too:
  • Are you bullish or bearish on Endymed? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Endymed? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Endymed

I send you an email if I find something interesting about Endymed.


Comments

How you think about this?

Leave a comment

Stay informed about Endymed.

Receive notifications about Endymed in your mailbox!